Investment Opportunities in BioTech and Disruptive Innovation
Benefiting from the new listing chapter, Hong Kong has become the second largest and a leading biotech fundraising hub globally. Wanna Grasp this golden investment opportunity and follow frontier dynamics of the sector? In this webinar, Lester Chan from Saxo and Daniel Mak from ChinaAMC (HK) will be invited to discuss these topics:
- Recap takeaways from the Leadership Dialogue between Ms. Cathie Wood (CEO & CIO of ARK Invest) and Ms. Yimei LI (CEO of ChinaAMC)
- Unveil the story of BioTech industry and the first purely Hong Kong-listed names BioTech ETF (3069. HK)
Daniel Mak Vice President of Business Development, ChinaAMC (HK)
Lester Chan Head of Wealth Management for Greater China, Saxo Bank